UPDATE 1-Merck expects to be denied approval for sugammadex injection again

March 13 (Reuters) - Merck & Co Inc said it expects its long-delayed drug to reverse the effects of anesthesia to be denied U.S. approval after U.S. regulators said they need to conduct more site inspections related to a study of the drug.